{"id":"susu-xiao-er-zhike-granules","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Gastrointestinal upset"}]},"_chembl":{"chemblId":"CHEMBL564","moleculeType":"Small molecule","molecularWeight":"284.43"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of Susu Xiao'er Zhike Granules is not well understood, but it is believed to involve the modulation of immune responses and the reduction of inflammation. This may be achieved through the interaction of various bioactive compounds present in the formula, including flavonoids, alkaloids, and saponins.","oneSentence":"Susu Xiao'er Zhike Granules is a traditional Chinese medicine formula that has been studied for its potential anti-inflammatory and immunomodulatory effects.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:36:53.771Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of rheumatoid arthritis"}]},"trialDetails":[{"nctId":"NCT06773117","phase":"PHASE3","title":"Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment","status":"NOT_YET_RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2025-09-01","conditions":"Cough","enrollment":360},{"nctId":"NCT04457011","phase":"PHASE2","title":"Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children","status":"COMPLETED","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2020-09-19","conditions":"Cough","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Susu Xiao'er Zhike Granules","genericName":"Susu Xiao'er Zhike Granules","companyName":"Tasly Pharmaceutical Group Co., Ltd","companyId":"tasly-pharmaceutical-group-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Susu Xiao'er Zhike Granules is a traditional Chinese medicine formula that has been studied for its potential anti-inflammatory and immunomodulatory effects. Used for Treatment of rheumatoid arthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}